Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shock, Cardiogenic | 17 | 2024 | 709 | 2.490 |
Why?
|
Myocardial Infarction | 12 | 2024 | 11460 | 1.060 |
Why?
|
Negotiating | 1 | 2022 | 150 | 0.740 |
Why?
|
Pyridazines | 1 | 2022 | 202 | 0.740 |
Why?
|
National Library of Medicine (U.S.) | 1 | 2020 | 34 | 0.740 |
Why?
|
Airway Management | 1 | 2023 | 312 | 0.670 |
Why?
|
Registries | 11 | 2024 | 8224 | 0.620 |
Why?
|
Heart Failure | 7 | 2024 | 11669 | 0.590 |
Why?
|
Drug-Eluting Stents | 2 | 2022 | 681 | 0.540 |
Why?
|
Education, Distance | 1 | 2020 | 261 | 0.530 |
Why?
|
Cardiology | 3 | 2024 | 1656 | 0.520 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 840 | 0.510 |
Why?
|
Ischemia | 1 | 2024 | 1882 | 0.500 |
Why?
|
Carotid Artery Diseases | 2 | 2018 | 877 | 0.480 |
Why?
|
Coronary Stenosis | 1 | 2021 | 794 | 0.480 |
Why?
|
Embolism | 1 | 2018 | 399 | 0.470 |
Why?
|
Thrombolytic Therapy | 2 | 2023 | 2064 | 0.470 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 790 | 0.470 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15500 | 0.460 |
Why?
|
Coronary Vessel Anomalies | 1 | 2017 | 307 | 0.450 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1273 | 0.420 |
Why?
|
Patient Selection | 2 | 2024 | 4244 | 0.410 |
Why?
|
Quality Improvement | 3 | 2023 | 3801 | 0.410 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1725 | 0.410 |
Why?
|
Pulmonary Embolism | 2 | 2023 | 2567 | 0.400 |
Why?
|
Heart-Assist Devices | 5 | 2024 | 1287 | 0.400 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2118 | 0.390 |
Why?
|
Treatment Outcome | 26 | 2024 | 64680 | 0.390 |
Why?
|
Aspirin | 2 | 2024 | 3133 | 0.350 |
Why?
|
Aortic Valve Stenosis | 2 | 2022 | 2001 | 0.340 |
Why?
|
Catheters | 2 | 2023 | 427 | 0.340 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2022 | 1462 | 0.330 |
Why?
|
Warfarin | 1 | 2018 | 1483 | 0.330 |
Why?
|
Veterans | 1 | 2023 | 2647 | 0.320 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1555 | 0.320 |
Why?
|
Radial Artery | 2 | 2021 | 187 | 0.310 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1792 | 0.310 |
Why?
|
Hemodynamics | 4 | 2023 | 4159 | 0.310 |
Why?
|
Pulmonary Artery | 1 | 2017 | 1927 | 0.310 |
Why?
|
Aortic Valve | 1 | 2018 | 1955 | 0.300 |
Why?
|
Humans | 63 | 2024 | 761504 | 0.300 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2373 | 0.290 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3627 | 0.290 |
Why?
|
Fibrinolytic Agents | 3 | 2022 | 2084 | 0.280 |
Why?
|
Education, Medical | 1 | 2018 | 1725 | 0.280 |
Why?
|
Coronary Angiography | 2 | 2022 | 4471 | 0.270 |
Why?
|
Thrombectomy | 2 | 2022 | 705 | 0.260 |
Why?
|
Stroke | 2 | 2018 | 9757 | 0.250 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2024 | 2751 | 0.250 |
Why?
|
Aged | 24 | 2024 | 169289 | 0.240 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.240 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8002 | 0.240 |
Why?
|
Risk Factors | 16 | 2024 | 74206 | 0.230 |
Why?
|
Coronary Care Units | 2 | 2024 | 235 | 0.220 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 231 | 0.210 |
Why?
|
United States | 15 | 2024 | 72334 | 0.210 |
Why?
|
Cardiotonic Agents | 2 | 2022 | 539 | 0.210 |
Why?
|
Acute Disease | 2 | 2024 | 7237 | 0.210 |
Why?
|
Hydrazones | 1 | 2022 | 103 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
Time Factors | 10 | 2022 | 39967 | 0.200 |
Why?
|
Cardiac Output, Low | 1 | 2022 | 191 | 0.200 |
Why?
|
Etomidate | 1 | 2024 | 185 | 0.190 |
Why?
|
Frail Elderly | 2 | 2024 | 765 | 0.190 |
Why?
|
Anesthetics, Intravenous | 1 | 2024 | 395 | 0.180 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2018 | 942 | 0.170 |
Why?
|
Risk Assessment | 7 | 2024 | 23995 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.170 |
Why?
|
Geriatric Assessment | 2 | 2024 | 1410 | 0.170 |
Why?
|
Colchicine | 1 | 2020 | 259 | 0.160 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5127 | 0.160 |
Why?
|
Cause of Death | 2 | 2020 | 3683 | 0.160 |
Why?
|
Extremities | 1 | 2024 | 867 | 0.160 |
Why?
|
Medicare | 4 | 2023 | 6770 | 0.150 |
Why?
|
Internship and Residency | 1 | 2018 | 5880 | 0.150 |
Why?
|
Femoral Artery | 2 | 2020 | 826 | 0.150 |
Why?
|
Propofol | 1 | 2024 | 603 | 0.150 |
Why?
|
Secondary Prevention | 2 | 2024 | 1475 | 0.150 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6403 | 0.150 |
Why?
|
Incidence | 3 | 2021 | 21353 | 0.150 |
Why?
|
Palliative Care | 3 | 2022 | 3598 | 0.140 |
Why?
|
Regional Health Planning | 1 | 2017 | 96 | 0.140 |
Why?
|
Hemorrhage | 4 | 2024 | 3424 | 0.140 |
Why?
|
Transportation of Patients | 1 | 2017 | 174 | 0.140 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1733 | 0.140 |
Why?
|
Coronary Thrombosis | 1 | 2019 | 440 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3245 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2020 | 973 | 0.130 |
Why?
|
Career Choice | 1 | 2022 | 756 | 0.130 |
Why?
|
Research Personnel | 1 | 2021 | 588 | 0.130 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 737 | 0.130 |
Why?
|
Clinical Competence | 2 | 2024 | 4792 | 0.130 |
Why?
|
Cardiology Service, Hospital | 1 | 2017 | 239 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10209 | 0.130 |
Why?
|
Vascular System Injuries | 1 | 2019 | 246 | 0.130 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 343 | 0.130 |
Why?
|
Male | 18 | 2024 | 360804 | 0.120 |
Why?
|
Interleukin-8 | 1 | 2018 | 695 | 0.120 |
Why?
|
Female | 20 | 2024 | 392644 | 0.120 |
Why?
|
Sirolimus | 1 | 2022 | 1533 | 0.120 |
Why?
|
Hospital Mortality | 3 | 2024 | 5294 | 0.120 |
Why?
|
Prevalence | 2 | 2024 | 15732 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 592 | 0.120 |
Why?
|
Hospitalization | 4 | 2022 | 10723 | 0.120 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2188 | 0.110 |
Why?
|
Workflow | 1 | 2018 | 851 | 0.110 |
Why?
|
Electronic Health Records | 2 | 2021 | 4811 | 0.110 |
Why?
|
Patient Care Team | 1 | 2024 | 2521 | 0.110 |
Why?
|
Goals | 1 | 2018 | 711 | 0.110 |
Why?
|
Myocardial Ischemia | 1 | 2023 | 2113 | 0.100 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2628 | 0.100 |
Why?
|
Retrospective Studies | 6 | 2024 | 80636 | 0.100 |
Why?
|
Heart Arrest | 1 | 2022 | 1514 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1444 | 0.090 |
Why?
|
Hypoglycemic Agents | 2 | 2022 | 3085 | 0.090 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2024 | 284 | 0.090 |
Why?
|
Oxygen | 1 | 2022 | 4227 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1421 | 0.090 |
Why?
|
Middle Aged | 12 | 2024 | 220895 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3879 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2471 | 0.090 |
Why?
|
Survival Rate | 1 | 2024 | 12725 | 0.090 |
Why?
|
Computer Simulation | 1 | 2023 | 6240 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58976 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2023 | 2183 | 0.080 |
Why?
|
Databases, Factual | 2 | 2023 | 7967 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1496 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8529 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2022 | 3889 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2942 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2220 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2024 | 3408 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1923 | 0.070 |
Why?
|
Anticoagulants | 2 | 2023 | 4812 | 0.070 |
Why?
|
Cognition | 1 | 2024 | 6990 | 0.070 |
Why?
|
Prognosis | 4 | 2023 | 29625 | 0.070 |
Why?
|
Age Factors | 2 | 2024 | 18395 | 0.060 |
Why?
|
Heart Diseases | 1 | 2019 | 2781 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10766 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3358 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8708 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2018 | 12341 | 0.060 |
Why?
|
Lactates | 1 | 2023 | 405 | 0.050 |
Why?
|
Forecasting | 2 | 2024 | 2928 | 0.050 |
Why?
|
Myocardial Reperfusion | 1 | 2023 | 338 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7390 | 0.050 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2022 | 223 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 13367 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2023 | 930 | 0.040 |
Why?
|
Algorithms | 1 | 2021 | 14031 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15631 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2024 | 3745 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10773 | 0.040 |
Why?
|
Ambulances | 1 | 2018 | 91 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7879 | 0.040 |
Why?
|
Punctures | 1 | 2019 | 366 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1039 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 464 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39106 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2024 | 1179 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1750 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1202 | 0.030 |
Why?
|
Cost of Illness | 1 | 2024 | 1936 | 0.030 |
Why?
|
Catheterization | 1 | 2020 | 1428 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1597 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20570 | 0.030 |
Why?
|
India | 1 | 2020 | 2348 | 0.030 |
Why?
|
Albuterol | 1 | 1974 | 213 | 0.030 |
Why?
|
Biomedical Research | 2 | 2019 | 3429 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1241 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2019 | 2115 | 0.020 |
Why?
|
Critical Care | 1 | 2024 | 2696 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2018 | 1039 | 0.020 |
Why?
|
Health Care Costs | 1 | 2024 | 3242 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1516 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4404 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8631 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3179 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4346 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36426 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2723 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2495 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2979 | 0.020 |
Why?
|
Patient Readmission | 1 | 2022 | 3270 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.020 |
Why?
|
Decision Making | 1 | 2019 | 3929 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10508 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26125 | 0.010 |
Why?
|
Adult | 3 | 2023 | 221177 | 0.010 |
Why?
|
Asthma | 1 | 1974 | 6234 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54425 | 0.010 |
Why?
|
Pulse | 1 | 1974 | 217 | 0.010 |
Why?
|
Vital Capacity | 1 | 1974 | 971 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168459 | 0.000 |
Why?
|
Blood Pressure | 1 | 1974 | 8481 | 0.000 |
Why?
|
Adolescent | 1 | 1974 | 88319 | 0.000 |
Why?
|
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_